Binaxnow covid-19 tests

Ended Awarded Last action

Contract number
36C25924F0067
Awardee
Awarding agency
Obligated
$81,825

Award facts

Contract value 100% obligated
$81,824.68 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Aurora, CO 80045, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00009 -$4,020
Supplemental Agreement for work within scope P00008 -$81,236
Other Administrative Action P00007 · Decrease binaxnow covid-19 home tests for oklahoma city -$5,065
Supplemental Agreement for work within scope P00006 · Increase binaxnow covid-19 home tests for cheyenne (442-C49052) -$41,679
Funding Only Action P00005 · Decrease binaxnow covid-19 home tests for FT harrison (436-C40093) -$3,739
Funding Only Action P00004 -$6,895
Supplemental Agreement for work within scope P00003 · Increase binaxnow covid-19 home tests for cheyenne (442-C49052) $5,017
Funding Only Action P00002 $6,030
Other Administrative Action P00001 $0
Original award $213,412

About this award

Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $81,824.68 on December 15, 2023, for BinaxNOW COVID-19 antigen tests to be delivered to Oklahoma City. This is a firm fixed-price delivery order with an ultimate completion date of December 14, 2024, issued under the General Services Administration Schedule 65-VII (In Vitro Diagnostics, Reagents, Test) contract vehicle. The award was funded by Veterans Integrated Service Network 19, a component of the Department of Veterans Affairs, and carries no small business set-aside designation. The place of performance is identified as Aurora, Colorado.

This delivery order represents continued federal procurement of COVID-19 diagnostic testing supplies from Abbott, which has established itself as a critical supplier of point-of-care testing devices and rapid antigen tests across multiple VA Integrated Service Networks and federal healthcare agencies. Abbott's extensive portfolio with the VA includes numerous blanket purchase agreements and delivery orders for diagnostic testing services, positioning the company as a primary vendor for federal healthcare procurement operations. The award demonstrates the VA's ongoing reliance on rapid diagnostic testing capabilities to support clinical operations and public health readiness across its regional service networks.

Quick answers

Who was awarded contract 36C25924F0067?

36C25924F0067 was awarded to Abbott Rapid DX North America LLC by Veterans Integrated Service Network 19 (Veterans Health Administration) on December 15, 2023.

How much is contract 36C25924F0067 worth?

The government has obligated $81,825 on 36C25924F0067.

Is contract 36C25924F0067 an order under another contract?

Yes. 36C25924F0067 is a delivery order under 36F79721D0073, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract 36C25924F0067 competed?

The extent of competition for 36C25924F0067 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award